|Daily Range||0.00 - 0.00|
|52-Week Range||0.00 - 0.00|
|Dividend (Yield)||0.00 (0.0%)|
|Average Daily Volume||0|
|Current FY EPS||-7.14|
RECEPTOS INC (RCPT) Description
RECEPTOS INC Website: http://www.receptos.com/
Celgene trounced Wall Street's expectations in the second quarter, but it's these five things that its management team most wants you to know.
Receptos is being acquired by Celgene in a deal valued at more than $7 billion.
Celgene logs a 13% gain in July, and in the process joins an elite class of biotech stocks having crested the $100 billion value mark. Find out if Celgene's good fortune can continue.